Castle Biosciences
NasdaqGM:CSTL
$ 23,13
$-0,30 (-1,28%)
23,13 $
$-0,30 (-1,28%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-0,83
Earnings Per Share
$11,58
Revenue Per Share
79,37%
Gross Margin %
$0,69 B
Market Cap
$0,01 B
Long-Term Debt
Earnings Per Share
$-0,83
Revenue Per Share
$11,58
Gross Margin %
79,37%
Market Cap
$0,69 B
Long-Term Debt
$0,01 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018
EPS Earnings Per Share $-0,83 $0,62 $-2,14 $-2,58 $-1,24 $-0,47 $-0,25 $-0,51
Earnings Earnings $-24,68M $17,68M $-58,74M $-68,58M $-31,51M $-11,74M $-4,30M $-0,98M
RPS Revenue Per Share $0,00 $11,58 $11,65 $8,01 $5,16 $3,70 $2,51 $3,02 $11,87
Revenue Revenue $0,00M $344,23M $332,07M $219,79M $137,04M $94,09M $62,65M $51,87M $22,79M
OCF Operating Cash Flow $0,00M $52,70M $64,87M $-5,63M $-41,66M $-18,13M $9,87M $7,02M $0,00M
FCF Free Cash Flow $0,00M $7,85M $36,54M $-32,11M $-47,29M $-22,47M $5,11M $6,08M $0,00M
OM Operating Margin 0,00% -12,44% 2,61% -30,93% -66,51% -42,60% -13,45% 14,13% 0,00%
GM % Gross Margin % 0,00% 79,37% 81,87% 79,53% 76,64% 83,18% 84,54% 85,91% 0,00%
FCFS Free Cash Flow Per Share $0,00 $0,98 $1,32 $-0,72 $-1,81 $-0,89 $0,27 $0,71 $0,00
LT Debt Long-Term Debt N/A $9,64M $9,75M N/A N/A N/A N/A $19,29M $24,50M
Sha. Stocks 29,73M 29,73M 28,51M 27,45M 26,58M 25,41M 24,98M 17,19M 1,92M
×